1. Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients – evidence from a large observational cohort. Issue 3 (4th March 2019) Authors: Bavaro, D. F.; Di Carlo, D.; Zuccalà, P.; Bai, F.; Incardona, F.; Battisti, A.; Giachè, S.; Salomoni, E.; Gagliardini, R.; Di Giambenedetto, S.; Pecorari, M.; Zazzi, M.; De Luca, A.; Bezenchek, A.; Lo Caputo, S. Journal: Infectious diseases Issue: Volume 51:Issue 3(2019) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗